Android 16's new 90:10 split-screen mode makes launching, using, and switching between two apps a more realistic productivity hack.

A former Senior Publishing Editor on the Dow Jones Newswires team at The Wall Street Journal, Aaron earned a Bachelor's degree in Economics from the University of Michigan and a Master's in Journalism ...

ATHENS, Greece, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Rubico Inc. (Nasdaq: RUBI) (the “Company” or “Rubico”), a global provider of shipping transportation services specializing in the ownership of vessels ...

This is important because: You can view and use multiple webpages inside a single Opera window, without installing any extensions or opening new tabs in separate ...

Tilray Brands Inc (NASDAQ: TLRY) shares are trading lower in Wednesday’s after-hours session after the company announced a reverse stock split. What To Know: After the market close on Wednesday, ...

YieldMax Ultra Option Income Strategy ETF has seen its NAV collapse 79% since inception. Its total return is now negative. ULTY's strategy of holding volatile stocks and writing call options has ...

MIDLAND, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson” or the “Company”), a technology company that ...

LOS ANGELES--(BUSINESS WIRE)--Hudson Pacific Properties, Inc. ("Hudson Pacific" or the "Company") (NYSE: HPP) today announced that it will effect a 1-for-7 reverse stock split (the "Reverse Stock ...

In a bid to get it above the $1.00/share NASDAQ-required minimum, fledgling EV brand Polestar ($PSNY) is rumored to be considering a 1:30 reverse stock split that ...

Chris is a writer and editor with over 10 years of experience covering games and has a bachelor's degree in History from the University of Central Lancashire. He's mainly focused on guides, but has ...

Q3 net loss widens to $365 million from $323 million a year ago Revenue jumps 36% in Q3, but tariffs and costs hit margins Shares drop as much as 17% Nov 12 (Reuters) - Polestar reported a wider third ...

ZURICH, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and ...